Dr. John Hamm, MD
Claim this profileNorton Cancer Institute
Expert in Non-Small Cell Lung Cancer
Studies Cancer
24 reported clinical trials
44 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
2Cancer
Stage IV
Stage III
PD-L1 positive
Affiliated Hospitals
Clinical Trials John Hamm, MD is currently running
ONC-392 vs Chemotherapy
for Lung Cancer
This trial is testing gotistobart, a new drug that helps the immune system fight advanced lung cancer in patients who haven't responded to other treatments. It works by blocking a protein that allows cancer cells to hide from the immune system.
Recruiting2 awards Phase 310 criteria
Brentuximab Vedotin + Pembrolizumab
for Advanced Cancers
This trial will find out whether brentuximab vedotin and pembrolizumab work together to treat different types of cancer. There will be several different types of cancer studied in the trial. The cancer must have spread to other parts of the body (metastatic). The study will also find out what side effects occur. A side effect is anything the treatment does besides treat cancer. This is a multi-cohort study.
Recruiting1 award Phase 27 criteria
More about John Hamm, MD
Clinical Trial Related1 year of experience running clinical trials · Led 24 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments John Hamm, MD has experience with
- Pembrolizumab
- Cisplatin
- Atezolizumab
- Carboplatin
- INGN 201
- ONC-392
Breakdown of trials John Hamm, MD has run
Non-Small Cell Lung Cancer
Cancer
Lung Cancer
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John Hamm, MD specialize in?
John Hamm, MD focuses on Non-Small Cell Lung Cancer and Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is John Hamm, MD currently recruiting for clinical trials?
Yes, John Hamm, MD is currently recruiting for 8 clinical trials in Louisville Kentucky. If you're interested in participating, you should apply.
Are there any treatments that John Hamm, MD has studied deeply?
Yes, John Hamm, MD has studied treatments such as Pembrolizumab, Cisplatin, Atezolizumab.
What is the best way to schedule an appointment with John Hamm, MD?
Apply for one of the trials that John Hamm, MD is conducting.
What is the office address of John Hamm, MD?
The office of John Hamm, MD is located at: Norton Cancer Institute, Louisville, Kentucky 40202 United States. This is the address for their practice at the Norton Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.